Literature DB >> 7538974

Tenascin-C in serum: a questionable tumor marker.

S Schenk1, J Muser, G Vollmer, R Chiquet-Ehrismann.   

Abstract

In normal adult tissue tenascin-C (TN-C) is usually expressed at low levels. However, it is strongly induced in many tumors as well as in other pathological conditions often associated with inflammation. To evaluate the diagnostic significance of TN-C, we established a sensitive sandwich ELISA to determine TN-C levels in serum. Furthermore, we investigated the distribution of TN-C variants in serum and found the large TN-C isoforms to be predominant. We measured TN-C in sera from 15 healthy persons, 75 tumor patients and 84 patients selected due to their elevated levels of the acute-phase protein C-reactive protein (CRP), which is a very specific marker for infection and inflammation. It was found that sera from cancer patients can have elevated TN-C levels; however, the increase was more pronounced in persons with high levels of CRP. There appeared to be a correlation of TN-C levels with the levels of CRP. In view of these facts, the diagnostic value of TN-C levels in serum as a potential tumor marker seems to be questionable, since our data show that TN-C levels can be elevated as a consequence of infection and inflammation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7538974     DOI: 10.1002/ijc.2910610402

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  21 in total

Review 1.  Insidious changes in stromal matrix fuel cancer progression.

Authors:  Fayth L Miles; Robert A Sikes
Journal:  Mol Cancer Res       Date:  2014-01-22       Impact factor: 5.852

Review 2.  A complex interplay between the extracellular matrix and the innate immune response to microbial pathogens.

Authors:  Hannah Tomlin; Anna M Piccinini
Journal:  Immunology       Date:  2018-07-05       Impact factor: 7.397

3.  Accessing key steps of human tumor progression in vivo by using an avian embryo model.

Authors:  Martin Hagedorn; Sophie Javerzat; Delphine Gilges; Aurélie Meyre; Benjamin de Lafarge; Anne Eichmann; Andreas Bikfalvi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-21       Impact factor: 11.205

4.  The expression of tenascin-C and tenascin-W in human ossicles.

Authors:  Richard P Tucker; Cathryn A Peterson; Ismail Hendaoui; Sandrine Bichet; Ruth Chiquet-Ehrismann
Journal:  J Anat       Date:  2016-05-27       Impact factor: 2.610

5.  Tenascin-C Is Associated with Cored Amyloid-β Plaques in Alzheimer Disease and Pathology Burdened Cognitively Normal Elderly.

Authors:  Zhiping Mi; Willi Halfter; Eric E Abrahamson; William E Klunk; Chester A Mathis; Elliott J Mufson; Milos D Ikonomovic
Journal:  J Neuropathol Exp Neurol       Date:  2016-07-21       Impact factor: 3.685

Review 6.  Tenascins, a growing family of extracellular matrix proteins.

Authors:  R Chiquet-Ehrismann
Journal:  Experientia       Date:  1995-09-29

Review 7.  Internal Affairs: Tenascin-C as a Clinically Relevant, Endogenous Driver of Innate Immunity.

Authors:  Anna M Marzeda; Kim S Midwood
Journal:  J Histochem Cytochem       Date:  2018-01-31       Impact factor: 2.479

8.  A list of candidate cancer biomarkers for targeted proteomics.

Authors:  Malu Polanski; N Leigh Anderson
Journal:  Biomark Insights       Date:  2007-02-07

9.  Raised circulating tenascin-C in rheumatoid arthritis.

Authors:  Theresa H Page; Peter J Charles; Anna M Piccinini; Vicky Nicolaidou; Peter C Taylor; Kim S Midwood
Journal:  Arthritis Res Ther       Date:  2012-11-29       Impact factor: 5.156

10.  Endogenous control of immunity against infection: tenascin-C regulates TLR4-mediated inflammation via microRNA-155.

Authors:  Anna M Piccinini; Kim S Midwood
Journal:  Cell Rep       Date:  2012-10-19       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.